John Bell
John Bell
Professor of Medicine, University of Ottawa
Verified email at - Homepage
Cited by
Cited by
An integrated stress response regulates amino acid metabolism and resistance to oxidative stress
HP Harding, Y Zhang, H Zeng, I Novoa, PD Lu, M Calfon, N Sadri, C Yun, ...
Molecular cell 11 (3), 619-633, 2003
Oncolytic virotherapy
SJ Russell, KW Peng, JC Bell
Nature biotechnology 30 (7), 658-670, 2012
Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase
GE Hannigan, C Leung-Hagesteijn, L Fitz-Gibbon, MG Coppolino, ...
Nature 379 (6560), 91-96, 1996
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl, B Lichty, S Knowles, R Marius, H Atkins, N Sonenberg, JC Bell
Nature medicine 6 (7), 821-825, 2000
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl, BD Lichty, JM Paterson, AT Power, S Knowles, R Marius, ...
Cancer cell 4 (4), 263-275, 2003
ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
M Bi, C Naczki, M Koritzinsky, D Fels, J Blais, N Hu, H Harding, I Novoa, ...
The EMBO journal 24 (19), 3470-3481, 2005
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
J Heo, T Reid, L Ruo, CJ Breitbach, S Rose, M Bloomston, M Cho, HY Lim, ...
Nature medicine 19 (3), 329-336, 2013
The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
K Colwill, T Pawson, B Andrews, J Prasad, JL Manley, JC Bell, PI Duncan
The EMBO journal 15 (2), 265-275, 1996
Recent progress in the battle between oncolytic viruses and tumours
KA Parato, D Senger, PAJ Forsyth, JC Bell
Nature Reviews Cancer 5 (12), 965-976, 2005
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
J Hsu, JJ Hodgins, M Marathe, CJ Nicolai, MC Bourgeois-Daigneault, ...
The Journal of clinical investigation 128 (10), 4654-4668, 2018
Going viral with cancer immunotherapy
BD Lichty, CJ Breitbach, DF Stojdl, JC Bell
Nature Reviews Cancer 14 (8), 559-567, 2014
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
CJ Breitbach, J Burke, D Jonker, J Stephenson, AR Haas, LQM Chow, ...
Nature 477 (7362), 99-102, 2011
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
BH Park, T Hwang, TC Liu, DY Sze, JS Kim, HC Kwon, SY Oh, SY Han, ...
The lancet oncology 9 (6), 533-542, 2008
Activating transcription factor 4 is translationally regulated by hypoxic stress
JD Blais, V Filipenko, M Bi, HP Harding, D Ron, C Koumenis, BG Wouters, ...
Molecular and cellular biology 24 (17), 7469-7482, 2004
Vesicular stomatitis virus: re-inventing the bullet
BD Lichty, AT Power, DF Stojdl, JC Bell
Trends in molecular medicine 10 (5), 210-216, 2004
Oncolytic viruses as engineering platforms for combination immunotherapy
K Twumasi-Boateng, JL Pettigrew, YYE Kwok, JC Bell, BH Nelson
Nature Reviews Cancer 18 (7), 419-432, 2018
Translational control of the innate immune response through IRF-7
R Colina, M Costa-Mattioli, RJO Dowling, M Jaramillo, LH Tai, ...
Nature 452 (7185), 323-328, 2008
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
CJ Breitbach, JM Paterson, CG Lemay, TJ Falls, A McGuire, KA Parato, ...
Molecular Therapy 15 (9), 1686-1693, 2007
Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress
JD Blais, CL Addison, R Edge, T Falls, H Zhao, K Wary, C Koumenis, ...
Molecular and cellular biology 26 (24), 9517-9532, 2006
Cloning and characterization of a second member of the mouse mdr gene family
P Gros, M Raymond, J Bell, D Housman
Molecular and cellular biology, 1988
The system can't perform the operation now. Try again later.
Articles 1–20